ERISA Lawsuit Argues Pharmaceutical Company Ignored Outrageous 401(k) Fees
/In a recent ERISA lawsuit, plan fiduciaries allegedly failed to use the lowest cost share class for several mutual funds in a plan. They did not consider investment vehicles available at lower-costs. The plaintiffs claim the Pharmaceutical Product Development LLC Retirement Savings Plan fiduciaries have violated their fiduciary duties under the Employee Retirement Income Security Act (ERISA) since April 15, 2014.
Plan Fiduciaries Violated ERISA Failing to Use Lowest Cost Share Class:
Plaintiffs in the case claim that the plan fiduciaries failed to adequately (and objectively) review the plan investment portfolio to make sure that chosen investments were prudent both in terms of costs and maintenance of certain plan funds. This failure meant that ignoring other similar investment options that offered lower costs and better performance histories. Plaintiffs also allege that the fiduciaries failed to use the most economical cost share class for some mutual funds in the plan, and failed to contemplate collective trusts, separate accounts, or commingled accounts as options to the mutual funds (despite lower fees).
Plaintiffs Allege that Plan Fiduciaries Failed in Their Duties:
On average, 401(k) plans pay significantly lower fees than regular industry investors. This is true even as expense ratios for all continued to drop over the last several years. Additionally, the plan in question holds over $700 million in assets. The $700 million was managed since December 31, 2018, and the plan should have the ability to negotiate lower fees and invest in specific vehicles that require investment/balance minimums. The lawsuit documentation claims the plan funds have remained mostly unchanged through the past six years. As of 2018, plaintiffs were able to show data comparisons indicating over 60% of the plan funds were significantly more expensive than comparable funds in plans of a similar size.
Fulfilling a Fiduciary Responsibility for Retirement Plan Participants:
Plaintiffs argue that a prudent retirement plan fiduciary searches for and chooses the lowest-priced share class available. In this case, the plaintiffs’ fiduciaries failed to monitor the plan prudently and pinpoint whether or not it was invested in the lowest cost share class possible for the plan’s mutual funds. The plaintiffs also offered data illustrating how much more expensive the funds were in comparison to their similar situated options. Using more expensive share classes does not benefit plan participants in any way since the high-cost share classes did not provide any additional benefits or services. They did come with a consequence for plan participants, though.
If you need to discuss violations of fiduciary duty or would like to talk about filing an ERISA class action, we can help. Get in contact with Blumenthal Nordrehaug Bhowmik DeBlouw LLP. Experienced employment law attorneys are ready to assist you in any one of various law firm offices located in San Diego, San Francisco, Sacramento, Los Angeles, Riverside, and Chicago.